Current Tropical Medicine Reports

Current Tropical Medicine Reports is a review journal from Springer, issued from Cham in Switzerland since 2014, which asks specialists to survey recent advances in tropical medicine and holds a 2025 Journal Impact Factor of 2.4.《当前热带医学报告》是 Springer 在瑞士 Cham 出版的综述型期刊，2014 年创刊，请各领域专家梳理热带医学的近期进展，2025 年期刊影响因子 2.4。

Scope

• Original research is not among the article types. What the journal prints is review articles and invited commentaries, each weighing the literature of a topic and saying where the field now stands.原始研究不在受理体裁之列，刊物印出的是综述与受邀评论，逐篇衡量一个题目的文献，并交代该领域走到哪一步。

• Commissioning runs through section editors appointed for defined divisions of tropical medicine, who choose topics and hand them to experts, and each review annotates the few recent papers that mattered.组稿由分栏编辑承担，他们按热带医学的分支受聘，负责选定题目再交专家执笔，每篇综述都为几篇要紧的近作加注说明。

• Virology covers dengue, Zika, chikungunya, yellow fever and other arboviral threats, together with viral hepatitis and the haemorrhagic fevers met in tropical settings.病毒学一侧覆盖登革、寨卡、基孔肯雅与黄热等虫媒病毒威胁，病毒性肝炎与热带地区常见的出血热也在其中。

• Bacteriology takes in tuberculosis, leprosy, melioidosis, leptospirosis and the rickettsial diseases, with drug resistance and diagnostic delay treated as part of the problem rather than as background.细菌学收入结核、麻风、类鼻疽与钩端螺旋体病，立克次体病同样在内，耐药与诊断延误按问题本身对待，不当背景处理。

• Parasitology spans malaria, leishmaniasis, Chagas disease and sleeping sickness, the schistosomes and soil-transmitted helminths, and the cystic echinococcosis that persists around the Mediterranean.寄生虫学横跨疟疾、利什曼病、恰加斯病与昏睡病，血吸虫与土源性蠕虫在列，地中海周边持续存在的囊型棘球蚴病也归此栏。

• Entomology and vector biology take mosquitoes, ticks, triatomine bugs, fleas and lice, with control programs read against the insecticide resistance that keeps eroding them.昆虫学与媒介生物学处理蚊、蜱、锥蝽、蚤与虱，防制方案要对照不断侵蚀其效果的杀虫剂抗性来读。

• Immunology, cell biology and molecular biology supply the mechanistic side, from host response and immune evasion to the molecular targets on which diagnostics and vaccines are built.免疫学、细胞生物学与分子生物学提供机理一侧，从宿主反应与免疫逃逸，到诊断与疫苗所依托的分子靶点。

• Epidemiology and its molecular branch handle outbreak reconstruction, surveillance gaps and genotyping, which is where much of the recent Latin American and Mediterranean material comes from.流行病学与分子流行病学负责暴发回溯、监测缺口与基因分型，近年的拉美与地中海稿件多出自这一侧。

• Ecology and One Health are treated as working subjects, covering climate shifts, land use, reservoir and vector habitats, and the animal-human interface at which emergence happens.生态学与同一健康按研究题目处理，气候变动、土地利用、宿主与媒介生境都在其中，新发感染发生的动物与人交界同样受理。

• Behavioral science and health systems research cover care-seeking, adherence and the delivery failures that let treatable disease go untreated, with clinical medicine alongside.行为科学与卫生体系研究覆盖就医行为、依从性，以及让可治病症得不到治疗的交付短板，临床医学与之并列。

• Fungal disease has a section of its own, running from paracoccidioidomycosis and chromoblastomycosis to cryptococcosis and the resistant Candida auris lineages now spreading.真菌病单设一栏，从副球孢子菌病与着色芽生菌病，到隐球菌病与正在扩散的耐药耳念珠菌谱系。

• Pediatric global health and travel medicine cover children in endemic settings, resettled refugee families and travelers who come home with fever.儿科全球健康与旅行医学覆盖疫区儿童、重新安置的难民家庭，以及归国后发热的旅行者。

• Metabolism in tropical medicine is a newer heading, taking nutritional status, growth and the metabolic load that infection adds to chronic disease.热带医学中的代谢是较新的一栏，受理营养状况、生长发育，以及感染给慢性病添上的代谢负担。

• Topical Collections give the list its geography, with open calls on neglected diseases of the Americas, HIV and tropical medicine, tropical medicine in the Mediterranean region, and emerging technologies in Latin America.专题合集给这份清单加上地理坐标，美洲的被忽视疾病、HIV 与热带医学、地中海区域热带医学、拉美新兴技术与卫生研究都在组稿之列。

History

• The first paper went online in December 2013, a short piece on ocular larva migrans, and it appeared in volume 1, issue 1, dated March 2014, at pages 69 to 73.首篇论文于 2013 年 12 月上线，讨论眼部幼虫移行症，刊在第 1 卷第 1 期第 69 至 73 页，该期标注 2014 年 3 月。^[1]

• Volume 1 ran from March to December 2014 in four issues, and the same March, June, September and December pattern held for the next ten volumes.第 1 卷自 2014 年 3 月出到 12 月，共 4 期，此后十卷沿用 3 月、6 月、9 月与 12 月的节律。

• Springer brought the title out from Cham under its medical imprint, recorded by the National Library of Medicine as Springer International Publishing AG and now copyrighted to Springer Nature Switzerland AG.刊物由 Springer 在 Cham 出版，美国国家医学图书馆（National Library of Medicine）登记其出版方为 Springer International Publishing AG，版权行今署 Springer Nature Switzerland AG。

• There has never been a print edition. The journal exists online alone, under the electronic ISSN 2196-3045, the only ISSN it has been given.刊物自始没有印刷版，只以电子形式存在，电子刊号为 2196-3045，这也是它唯一的刊号。

• The title belongs to Springer's Current Reports line of review journals, and its submission rules refer to the family simply as Current Reports.刊物属于 Springer 的 Current Reports 综述刊系列，投稿说明至今仍以 Current Reports 指称这一系列。

• Volume 12, the 2025 volume, dropped the quarterly parts. Each volume now appears as a single issue, and papers are numbered as articles rather than paginated inside a part.2025 年的第 12 卷取消季度分册，每卷只出一个期号，论文按文章编号编排，不再在分册内另编页码。

• Volume 13 has run that way through 2026, reaching article 22 by early October, with most of the year's papers gathered into topical collections.第 13 卷沿此制走到 2026 年，10 月上旬已编到第 22 号，当年论文大多归入专题合集。

• Clarivate indexes the journal in the Emerging Sources Citation Index rather than the Science Citation Index Expanded, and its Journal Citation Reports entries sit in three ESCI categories.Clarivate 把刊物收在 Emerging Sources Citation Index，而没有进 Science Citation Index Expanded，期刊引证报告里它占三个 ESCI 类目。

• PubMed carries selected citations only, a partial listing rather than full coverage, and MEDLINE does not index the title at all.PubMed 只收选摘，属于部分著录而非完整收录，MEDLINE 则完全不收本刊。

• Scopus, EMBASE, CAB Abstracts, Reaxys and ProQuest appear on the publisher's abstracting list, which puts the title in front of agricultural and pharmacological readers as well as clinical ones.出版方的摘要与索引清单上还有 Scopus、EMBASE、CAB Abstracts 与 Reaxys，ProQuest 同样在列，刊物因此也进入农业与药学读者的视野。

• The Journal Impact Factor stood at 3.6 in 2023, fell to 2.1 in 2024 and recovered to 2.4 in 2025, against a five-year figure of 3.9.期刊影响因子 2023 年为 3.6，2024 年降至 2.1，2025 年回到 2.4，五年影响因子为 3.9。

• Within its categories the 2025 placement is 80th of 141 in infectious diseases, 19th of 47 in parasitology and 13th of 27 in tropical medicine.2025 年的类目位次是传染病学 141 种中第 80，寄生虫学 47 种中第 19，热带医学 27 种中第 13。

• Access is hybrid. Authors may open an article under an open license for a fee, gold open access accounts for about 30 percent of the output, and the site lists 52 open articles.访问模式为混合开放获取，作者付费即可按开放许可发表单篇，金色开放获取约占三成，站点现列 52 篇开放文章。

Editors

• Two editors-in-chief head the journal, Rojelio Mejia and Cristina Poveda, and both work from Baylor College of Medicine in Houston.两位主编分别是（Rojelio Mejia）与（Cristina Poveda），都在休斯顿的贝勒医学院（Baylor College of Medicine）任职。

• Baylor runs a National School of Tropical Medicine, so the editorial office sits inside an institution built around the journal's own subject.贝勒医学院设有国立热带医学院（National School of Tropical Medicine），编辑部因此设在一所以热带医学为专职的学院里。

• Nine subject sections carry the commissioning, each with a named section editor, and eleven people hold those posts between them.组稿依托 9 个学科分栏，每栏设分栏编辑，11 人分任其职。

• Six of the eleven work in Latin America, in Bolivia, Mexico, Guatemala, Colombia and Argentina, a spread that fits the journal's Latin American collections.11 位分栏编辑中有 6 位在拉美工作，分布在玻利维亚、墨西哥、危地马拉、哥伦比亚与阿根廷，与刊物的拉美专题相合。

• Two sections show the range, with vector-borne diseases under Julio Vladimir Cruz-Chan at the Autonomous University of Yucatán and tropical mycoses under Luis Martinez at the University of Florida.分栏的两端可以见出范围的宽度。虫媒病由尤卡坦自治大学（Autonomous University of Yucatán）的（Julio Vladimir Cruz-Chan）负责，热带真菌病交给佛罗里达大学（University of Florida）的（Luis Martinez）。

• Fabrizio Bruschi of Pisa takes the Mediterranean section, Anna Mandalakas and Diane Nguyen take pediatric global health at Baylor, and Ana Sanchez and Ariel Toloza share neglected diseases of the Americas.比萨大学（University of Pisa）的（Fabrizio Bruschi）主持地中海分栏，贝勒医学院的（Anna Mandalakas）与（Diane Nguyen）负责儿科全球健康，美洲被忽视疾病由（Ana Sanchez）与（Ariel Toloza）共同主持。

• HIV and tropical medicine, metabolism, molecular epidemiology and emerging technologies in Latin America account for the other four sections.其余四栏分别是 HIV 与热带医学、代谢、分子流行病学，以及拉美新兴技术与卫生研究。

• Five more people sit on the editorial board, from Riyadh, New Haven, Bamako, Nashville and Mérida, so the full masthead runs to eighteen names.编委会另有 5 人，分别来自利雅得、纽黑文、巴马科、纳什维尔与梅里达，整张刊头共 18 人。

• Review is single-blind. Referees see author names and affiliations, and their reports reach authors without the referee's name attached.评审采用单盲制，审稿人看得到作者姓名与单位，审稿意见回到作者手里时不带审稿人姓名。

• A submission is screened for plagiarism, then sent to one or two section editors or board members with the relevant expertise, who may call in outside referees.稿件先过查重，再交给一至两位对口的分栏编辑或编委，必要时另请外部审稿人。

• Revisions run in further rounds where needed, and the decision rests with the section editor who handled the paper or with the editor-in-chief.需要时再走一轮或数轮修改，决定权落在经手的分栏编辑或主编手上。

• Invited reviews dominate, but unsolicited manuscripts are read, provided a cover letter states the paper's contribution, its section and any conflicts of interest.刊物以邀稿综述为主，未经邀约的稿件也受理，前提是附信写明论文的贡献、拟投分栏与利益冲突。

• The house format caps the main text at 4,000 words, asks for Vancouver references and a Key References list of three to six annotated items.格式上限是正文 4000 词，参考文献用 Vancouver 格式，另附 3 至 6 条带注释的关键参考文献。

• Speed is a selling point. The publisher reports a median of four days from submission to first decision, and 160,300 downloads in 2025.速度是刊物的卖点，出版方给出的投稿到首次决定中位时间为 4 天，2025 年下载量 16.03 万次。

• If an editor or board member appears among the authors, that person steps out of the process and a colleague takes the paper.主编、分栏编辑或编委若出现在作者名单里，本人退出该稿流程，改由其他编辑接手。